iobenguane mibg aralkylguanidine analog adrenergic neurotransmitter norepinephrine noradrenaline typically used acts blocking agent adrenergic neurons radiolabeled used nuclear medicinal diagnostic therapy techniques well neuroendocrine chemotherapy treatments localizes adrenergic tissue thus used identify location tumors pheochromocytomas also used treat tumor cells take metabolize norepinephrine mibg absorbed accumulated granules adrenal medullary chromaffin cells well presynaptic adrenergic neuron granules process occurs closely related mechanism employed norepinephrine transporter norepinephrine transporter net functions provide norepinephrine uptake synaptic terminals adrenal chromaffin cells mibg bonding net finds roles imaging therapy less administered mibg gets metabolized miodohippuric acid miha mechanism metabolite produced mibg concentrates endocrine tumors commonly neuroblastoma paraganglioma pheochromocytoma also accumulates norepinephrine transporters adrenergic nerves heart lungs adrenal medulla salivary glands liver spleen well tumors originate neural crest labelled serves wholebody noninvasive scintigraphic screening germline somatic benign malignant neoplasms originating adrenal glands detect intra extraadrenal disease imaging highly sensitive iobenguane concentrates presynaptic terminals heart autonomically innervated organs enables possible noninvasive use vivo probe study alternatives imaging certain indications clinical research use include positronemitting isotope radiopharmaceuticals positron emission tomography imaging gamma camera offer significantly higher costeffectiveness availability compared pet imaging particularly effective therapy subsequently planned due directly comparable side effects post imaging rare include tachycardia pallor vomiting abdominal mibg radiolabelled beta emitting radionuclide treatment certain pheochromocytomas paragangliomas carcinoid tumors neuroblastomas medullary thyroid thyroid blockade nonradioactive potassium iodide indicated nuclear medicine scintigraphy iobenguanemibg competitively inhibits radioiodine uptake preventing excessive radioiodine levels thyroid minimizing risk thyroid ablation treatment minimal risk thyroid cancer also reduced dosing regime fdaapproved commercial product adreview potassium iodide lugols solution containing mg iodide weight adjusted children given hour eanm guidelines endorsed snmmi suggest variety regimes clinical use children product labeling diagnostic iobenguane recommends giving potassium iodide one day injection continuing days iobenguane used therapeutic purposes requires different premedication duration beginning hours iobenguane injection continuing days iobenguane marketed trade name azedra clinical trial treatment malignant recurrent unresectable pheochromocytoma paraganglioma fda approved july drug developed progenics httpsenwikipediaorgwikiiobenguane